Literature DB >> 31897946

Biochemical parameters in determination of nutritional status in amyotrophic lateral sclerosis.

Beata Chełstowska1,2, Magdalena Kuźma-Kozakiewicz3,4.   

Abstract

OBJECTIVES: Amyotrophic lateral sclerosis (ALS) is a fatal, neurodegenerative disorder without effective treatment. Progressive dysphagia, depression, and hypermetabolism may lead to malnutrition. The aim of the present study was to analyze the potential utility of readily available, relatively inexpensive, and rapid strategy for using laboratory parameters to assess nutritional status of ALS patients.
METHODS: This study included 203 patients with ALS. The analysis of inflammatory parameters: C Reactive Protein (CRP), erythrocyte sedimentation rate (ESR), white blood cell count (WBC), lymphocytes number (LN), and fibrinogen concentration (FC) was followed by nutritional markers: serum concentration of albumin (ALB), prealbumin (PALB), transferrin (TRNF), and creatinine (CREA), which were correlated with demographic and clinical parameters: body mass index (BMI), ALS phenotype, disease duration, diagnosis delay, and functional and respiratory assessment.
RESULTS: Nearly 20% of patients had biochemical features of inflammation. Among patients without inflammation (n = 163), a decreased serum TRNF concentration was found in 84% of cases, PALB in 39%, ALB in 25%, and CREA in 53%. The median of PALB was the highest in patients with PMA (23.5 mg/dL) and the lowest in PBP (16.6 mg/dL) (p < 0.05). The CREA concentration correlated with the BMI (r = 0.25; p < 0.01), while PALB and TRNF significantly varied depending on the severity of dysphagia. Patients with dysphagia qualified to enteral nutrition showed significantly decreased concentration of PALB, triglycerides, as well as reduced forced vital capacity, BMI, and functional status.
CONCLUSIONS: CREA, PALB, ALB, and TNFR are easily accessible, accurate, and low-cost parameters useful in assessment of the nutritional status in ALS.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; BMI; Nutritional parameters; Nutritional status

Year:  2020        PMID: 31897946     DOI: 10.1007/s10072-019-04201-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  8 in total

1.  Stress load and neurodegeneration after gastrostomy tube placement in amyotrophic lateral sclerosis patients.

Authors:  L Brylev; V Fominykh; V Chernenkaia; I Chernenkiy; K Gorbachev; A Ataulina; A Izvekov; M Monakhov; A Olenichev; S Orlov; I Turin; M Loginov; S Rautbart; A Baymukanov; V Parshikov; V Demeshonok; A Yakovlev; T Druzhkova; A Guekht; N Gulyaeva
Journal:  Metab Brain Dis       Date:  2021-09-24       Impact factor: 3.584

2.  Blood-brain barrier dysfunction and myelin basic protein in survival of amyotrophic lateral sclerosis with or without frontotemporal dementia.

Authors:  Jin-Yue Li; Zheng-Yi Cai; Xiao-Han Sun; Dong-Chao Shen; Xun-Zhe Yang; Ming-Sheng Liu; Li-Ying Cui
Journal:  Neurol Sci       Date:  2021-11-26       Impact factor: 3.830

Review 3.  C-reactive protein levels in patients with amyotrophic lateral sclerosis: A systematic review.

Authors:  Sanjeev Kharel; Rajeev Ojha; Veeramani Preethish-Kumar; Riwaj Bhagat
Journal:  Brain Behav       Date:  2022-02-24       Impact factor: 2.708

4.  Correlation of weight and body composition with disease progression rate in patients with amyotrophic lateral sclerosis.

Authors:  Jin-Yue Li; Xiao-Han Sun; Zheng-Yi Cai; Dong-Chao Shen; Xun-Zhe Yang; Ming-Sheng Liu; Li-Ying Cui
Journal:  Sci Rep       Date:  2022-08-02       Impact factor: 4.996

5.  Analysis of routine blood parameters in patients with amyotrophic lateral sclerosis and evaluation of a possible correlation with disease progression-a multicenter study.

Authors:  Nora Hertel; Magdalena Kuzma-Kozakiewicz; Marta Gromicho; Julian Grosskreutz; Mamede de Carvalho; Hilmi Uysal; Reinhard Dengler; Susanne Petri; Sonja Körner
Journal:  Front Neurol       Date:  2022-07-27       Impact factor: 4.086

6.  Elevated Cerebrospinal Fluid Proteins and Albumin Determine a Poor Prognosis for Spinal Amyotrophic Lateral Sclerosis.

Authors:  Abdelilah Assialioui; Raúl Domínguez; Isidro Ferrer; Pol Andrés-Benito; Mónica Povedano
Journal:  Int J Mol Sci       Date:  2022-09-21       Impact factor: 6.208

7.  Correspondence: Importance of the validated serum biochemistry and hemogram parameters for rapid diagnosis and to prevent false negative results during COVID-19 pandemic.

Authors:  Duygu Aydemir; Nuriye Nuray Ulusu
Journal:  Biotechnol Appl Biochem       Date:  2020-05-21       Impact factor: 2.724

8.  Validation of the revised Amyotrophic Lateral Sclerosis Functional Rating Scale in Poland and its reliability in conditions of the medical experiment.

Authors:  Stanisław Maksymowicz; Paula Kukołowicz; Tomasz Siwek; Agnieszka Rakowska
Journal:  Neurol Sci       Date:  2020-07-16       Impact factor: 3.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.